Abstract Details
| Guy A. Rouleau, MD, PhD, FAAN (Montreal Neurological Institute and Hospital) | Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| George C. Ebers, MD | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Jose M. Pereira-Monteiro, MD, PhD (Neuroendocrino) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Sylvain Chouinard, MD (CHUM-Notre-Dame) | No disclosure on file |
| Bernard Brais, MD | Dr. Brais has nothing to disclose. |
| Patrick Cossette, MD (CHUM) | No disclosure on file |
| No disclosure on file |